Market cap: 870 M
Total Stockholder Equity: 170 M (30/11/12)
Market cap: 845 M
Total Stockholder Equity: 177 M (30/11/12)
Cash: 296 M
Market cap: 690 M
Total shareholders' equity (deficit): $ (4,566 ) M (30/11/12)
Cash: 38 M
Especially SRPT stock action is impressive with only one drug in phase II .
Ask the Crooke who is running out of cash real fast!